INCREASED RENAL PLASMA-FLOW IN LONG-TERM ENALAPRIL TREATMENT OF HYPERTENSION

被引：67

作者：

SIMON, G ^{[1
]}

MORIOKA, S ^{[1
]}

SNYDER, DK ^{[1
]}

COHN, JN ^{[1
]}

机构：

[1] UNIV MINNESOTA, DEPT MED, MINNEAPOLIS, MN 55455 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 34卷 / 04期

关键词：

D O I：

10.1038/clpt.1983.198

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：459 / 465

页数：7

共 21 条

[1] COMPARISON OF THE HORMONAL AND RENAL EFFECTS OF CAPTOPRIL IN SEVERE ESSENTIAL AND RENOVASCULAR HYPERTENSION [J].

ALDIGIER, JC ;

PLOUIN, PF ;

GUYENE, TT ;

THIBONNIER, M ;

CORVOL, P ;

MENARD, J .

AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06) :1447-1452

[2] SIMPLIFIED HIPPURAN CLEARANCE - MEASUREMENT OF RENAL FUNCTION IN MAN WITH SIMPLIFIED HIPPURAN CLEARANCES [J].

BLAUFOX, MD ;

MERRILL, JP .

NEPHRON, 1966, 3 (05) :274-&

[3] PROTEINURIA DURING LONG-TERM CAPTOPRIL THERAPY [J].

CASE, DB ;

ATLAS, SA ;

MOURADIAN, JA ;

FISHMAN, RA ;

SHERMAN, RL ;

LARAGH, JH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (04) :346-349

[4]

CATIN M, 1979, P SOC EXP BIOL MED, V162, P121

[5]

GAVRAS H, 1978, CIRC RES, V43, pI59

[6] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION [J].

GAVRAS, H ;

BIOLLAZ, J ;

WAEBER, B ;

BRUNNER, HR ;

GAVRAS, I ;

DAVIES, RO .

CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) :303-314

[7]

GROSS DM, 1981, J PHARMACOL EXP THER, V216, P552

[8] MECHANISM OF THE BLOOD-PRESSURE AND RENAL HEMODYNAMIC-EFFECTS OF CAPTOPRIL [J].

HALL, JE ;

GRANGER, JP .

AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06) :1527-1529

[9] INCREASED GLOMERULAR-FILTRATION RATE AFTER CONVERTING-ENZYME INHIBITION IN ESSENTIAL HYPERTENSION [J].

HOLLENBERG, NK ;

SWARTZ, SL ;

PASSAN, DR ;

WILLIAMS, GH .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (01) :9-12

[10]

HOORNTJE SJ, 1980, LANCET, V1, P1212

← 1 2 3 →